Log In
BCIQ
Print this Print this
 

furaprevir (TG-2349)

  Manage Alerts
Collapse Summary General Information
Company TaiGen Biopharmaceuticals Holdings Ltd.
DescriptionHCV protease inhibitor
Molecular Target HCV NS3/4A protease complex
Mechanism of ActionViral protease inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsPrevent HCV infection; Treat chronic hepatitis C infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today